Print Page  |  Contact Us  |  Report Abuse  |  Sign In  |  Join ACAM
ACAM Integrative Medicine Blog
Blog Home All Blogs
Search all posts for:   

 

View all (301) posts »
 

ACAM to Welcome Gervasio "Tony" Lamas, MD to Spring Conference

Posted By Administration, Thursday, April 04, 2013
Updated: Wednesday, January 29, 2014

It is with great enthusiasm that ACAM announces that we have the distinct pleasure to host Gervasio Lamas, MD to our upcoming Spring 2013 conference and tradeshow. Dr. Lamas will be speaking on Saturday, June 1, 2013 as a special lunchtime presentation during ACAM's General Session proceedings.

Dr. Lamas will be discussing the Trial to Assess Chelation Therapy (TACT) which was a multi-center international collaborative study initiated in 2009. Sponsored by the National Center for Complementary and Alternative Medicine (NCCAM) and National Heart, Lung, and Blood Institute (NHLBI), Dr. Lamas was the lead investigator to determine the safety and effectiveness of EDTA chelation therapy in individuals with coronary artery disease. Dr. Lamas will be covering the TACT findings and its impact on the integrative medicine.

About Dr. Gervasio "Tony" Lamas

Gervasio A. (Tony) Lamas, M.D., is chief of Columbia University Division of Cardiology at Mount Sinai Medical Center in Miami Beach, Fla. and author of the TACT trial report. Dr. Lamas is the Chairman of Medicine at Mount Sinai Medical Center and Chief of the Columbia University Division of Cardiology at Mount Sinai Medical Center. He received his B.A. in Biochemical Sciences cum laude from Harvard College and his M.D. with honors (AOA) from New York University. He completed his Internship and Residency at the Brigham and Women's Hospital of Harvard Medical School, where he later served as Assistant Professor of Medicine. During the last decade, he has enrolled thousands of patients in more than a dozen U.S. and international trials in order to improve cardiac care and prevent death and disability from heart disease. He served as Chairman of the Mode Selection Trial in Sinus Node Dysfunction (MOST), a trial that led to profound changes in cardiac pacemakers. He served as Co-Chairman for the Occluded Artery Trial (OAT), and Study Chair for the Trial to Assess Chelation Therapy (TACT), a $30 million trial sponsored by the National Institutes of Health. He has authored over 300 scientific publications, and maintains an active clinical practice in Miami Beach and Key Biscayne.

About the Conference

ACAM's Spring 2013 Conference and Tradeshow will be hosted at the Westin Diplomat Resort in sunny Hollywood, FL Wednesday, May 29th - Sunday, June 2nd.
ACAM will offer pre-conference workshop learning opportunities in the areas of Lyme Disease & Biotoxin Illnesses, Basic Chelation Therapy (Heavy Metal Toxicology), Integrative Psychiatry, and Hyperbaric Oxygen Treatment presented by International Hyperbarics Association (IHA) on Wednesday, May 29th and Thursday, May 30th.

Our General Session, Mitochondria in Health and Disease: A Clinician's Guide to Diagnosis and Treatment, is designated for a maximum of 12.0 AMA PRA Category 1 Credits™ and will be hosted on Friday, May 31st - Sunday, June 2nd. Dr. Lamas will be our guest speaker at Saturday's lunch. All General Session attendees are automatically registered to hear this discussion.

ACAM will also be hosting its Certified Chelation Therapy Examination, is partnering with the Certification Board For Nutrition Specialists to host their examination, and will offer a multitude of bonus learning and networking opportunities.

For more information please visit www.acamflorida.com.

Tags:  alternative medicine  chelation therapy  complementary medicine  functional medicine  holistic medicine  integrative medicine  Spring Conference 

Share |
Permalink | Comments (0)
 
Community Search
Sign In


Forgot your password?

Haven't registered yet?

Calendar

9/14/2017 » 9/16/2017
ACAM 2017 Annual Meeting

Latest News